CARDIOXANE
Dead / Cancelled — Cancelled — Section 8 (as of 21 Mar 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86969771
- Registration number
- 5561522
- Mark type
- Stylized text
- Filed
- 08 Apr 2016
- Published for opposition
- 14 Nov 2017
- Registered
- 11 Sept 2018
- Attorney of record
- Tristram R. Fall, III, Esquire
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CANCER
Owner
- CNX THERAPEUTICS LIMITED, LONDON, GB
- Clinigen Healthcare Limited, Staffordshire, GB
- Clinigen Healthcare Limited, Staffordshire, GB
- Clinigen Healthcare Limited, Staffordshire, GB
Prosecution history
- 21 Mar 2025 — CANCELLED SEC. 8 (6-YR)
- 08 Nov 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jul 2018 — USE AMENDMENT FILED
- 25 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 09 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Nov 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2017 — PUBLISHED FOR OPPOSITION
- 25 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER